RSS   Newsletter   Contact   Advertise with us
Post Online Media

Intrexon senior vice president Samuel Broder to retire

IntrexonIntrexon Corporation, a biotechnology company, announced the retirement of Samuel Broder, senior vice president and head of Intrexon's health sector.

Dr. Broder has an extensive career in health and previously served as Chairman of the Health Sector and Executive Vice President of Scientific and Public Affairs for Intrexon.

READ MORE Intrexon: Mark F. Kubik vice president of business development

Prior to Intrexon, he was Executive Vice President and Chief Medical Officer at Celera and Senior Vice President of Research and Development at IVAX Corporation. He also served as Director of the National Cancer Institute (NCI) for six years.

During his tenure at NCI, Dr. Broder directed a number of large clinical trials and was instrumental in developing anti-cancer therapeutics as well as several drugs now widely used in the treatment of AIDS.

Dr. Broder has authored or co-authored more than 340 scientific publications, holds multiple patents, and is a member of the Institute of Medicine of the National Academy of Sciences. He received his M.D. from the University of Michigan.


 LATEST MOVES FROM Maryland 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy